1. Home
  2. EDSA vs CISO Comparison

EDSA vs CISO Comparison

Compare EDSA & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • CISO
  • Stock Information
  • Founded
  • EDSA 2015
  • CISO 2015
  • Country
  • EDSA Canada
  • CISO United States
  • Employees
  • EDSA N/A
  • CISO N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • EDSA Health Care
  • CISO Technology
  • Exchange
  • EDSA Nasdaq
  • CISO Nasdaq
  • Market Cap
  • EDSA 6.2M
  • CISO 5.9M
  • IPO Year
  • EDSA N/A
  • CISO N/A
  • Fundamental
  • Price
  • EDSA $2.36
  • CISO $0.57
  • Analyst Decision
  • EDSA Strong Buy
  • CISO
  • Analyst Count
  • EDSA 1
  • CISO 0
  • Target Price
  • EDSA $21.00
  • CISO N/A
  • AVG Volume (30 Days)
  • EDSA 8.9K
  • CISO 4.0M
  • Earning Date
  • EDSA 05-09-2025
  • CISO 05-19-2025
  • Dividend Yield
  • EDSA N/A
  • CISO N/A
  • EPS Growth
  • EDSA N/A
  • CISO N/A
  • EPS
  • EDSA N/A
  • CISO N/A
  • Revenue
  • EDSA N/A
  • CISO $30,750,695.00
  • Revenue This Year
  • EDSA N/A
  • CISO N/A
  • Revenue Next Year
  • EDSA N/A
  • CISO N/A
  • P/E Ratio
  • EDSA N/A
  • CISO N/A
  • Revenue Growth
  • EDSA N/A
  • CISO N/A
  • 52 Week Low
  • EDSA $1.55
  • CISO $0.26
  • 52 Week High
  • EDSA $5.59
  • CISO $3.84
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 51.83
  • CISO 52.37
  • Support Level
  • EDSA $2.29
  • CISO $0.44
  • Resistance Level
  • EDSA $2.40
  • CISO $0.64
  • Average True Range (ATR)
  • EDSA 0.12
  • CISO 0.07
  • MACD
  • EDSA 0.00
  • CISO 0.04
  • Stochastic Oscillator
  • EDSA 87.88
  • CISO 79.40

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: